Fueled by the growing focus on patient safety and technological advancements, the healthcare/medical simulation industry has experienced significant growth over the past decade, except for the past 3 to 4 years, where the market witnessed slow growth due to the global recession. A pivotal factor in the growth of this market has been high fidelity mannequins/patient simulators, which have witnessed substantial growth in recent years owing primarily to recent technological advancements that have created highly realistic simulators competent of very high levels of fidelity. Increasing healthcare costs, rising demand for minimally invasive treatment, and increasing consolidation of manufacturers further propels the market. However, the high cost of simulators, economic slowdown in the developed region, and limited availability of funds inhibits the growth of the market, to a certain extent.
The global healthcare/medical simulation market is broadly segmented into products and services. The market was valued at $790.1 million in 2012 and is poised to grow at a CAGR of 19.6% in the forecast period to reach $1930.5 million by 2017.
North America is the largest market for healthcare/medical simulation, with the U.S. contributing a major share, followed by Europe, and Asia. The Asian market, especially India and China, is expected to witness a boost in demand for medical simulation products and services and is poised to register maximum growth over the next five years, as a result of its economic development.
Prominent players in this market are Laerdal Medical (Norway), CAE Healthcare (Canada), Simulaids (U.S.), Gaumard (U.S.), Kyoto Kagako (Japan), Limbs and Things (U.K.), Education Management Solutions (U.S.), and Mentice AB (Sweden).
Scope of the report:
This research report largely categorizes the global market for healthcare/medical simulation into products and services. This market is broken down into segments and sub-segments, providing exhaustive value analysis for 2010, 2011 and 2012, as well as forecast up to 2017. The market is also evaluated by end-users and comprehensively analyzed at a granular level by region (North America, Europe, Asia, and Rest of the World (RoW).
Table of Content:-
1 INTRODUCTION 18
1.1 KEY TAKE-AWAYS 18
1.2 REPORT DESCRIPTION 18
1.3 MARKETS COVERED 19
1.4 STAKEHOLDERS 21
1.5 RESEARCH METHODOLOGY 22
1.5.1 MARKET SIZE 22
1.5.2 MARKET SHARE 22
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES 23
1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES 23
1.5.5 DETAILS OF PRIMARY INTERVIEWEES 24
1.5.6 ASSUMPTIONS 25
2 EXECUTIVE SUMMARY 26
3 MARKET OVERVIEW 29
3.1 INTRODUCTION 30
3.2 MARKET SEGMENTATION 31
3.3 MARKET DYNAMICS 33
3.3.1 DRIVERS 34
184.108.40.206 Increasing Healthcare Costs Create a Need for Medical Simulation Technologies 34
220.127.116.11 Continuous Innovation in Technologies to Drive the Market 34
18.104.22.168 Increasing Demand for Minimally Invasive Treatments is Projected to Fuel the Need for Medical Simulation 35
22.214.171.124 Increasing Focus on Patient Safety to Drive the Market 36
126.96.36.199 Increasing Consolidation of Manufacturers to Propel the Market 36
3.3.2 RESTRAINTS 37
For More Details on Related Reports Click on Below Link:
About JSB Market Research -
JSB Market Research is one of the most significant databases of online market researches and intelligence reports and services. The online portal for marketing research deals with access to global market data and assists in providing expert insights and exposure on global companies, industries, products and trends.
JSB Market Research Pvt. Ltd.
Office No-303, 3rd Floor, B Wing,
Hermes Atrium, Plot No-57, Sector - 11,
CBD - Belapur,
Navi Mumbai - 400614 - MH – INDIA
Tel- + 91 - 22 – 41236650 / +91 - 998 729 5242
Email - firstname.lastname@example.org